Clinical Trials in Preston, UK | Priya Life Science

Clinical Trials in Preston

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer

Exelixis

Phase 1

914

Middlesex, Preston, Cardiff, London

2017-09-05

Active, closed

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

NCT03155997Breast Cancer

Eli Lilly and Company

Phase 3

5,637

Truro, Chelmsford, London, Northwood, Blackpool, Preston, Boston, Central Middlesbrough

2017-07-12

Active, closed

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

NCT02531516Prostatic Neoplasms

Aragon Pharmaceuticals, Inc.

Phase 3

1,503

Aberdeen, Birmingham, Bristol, Derby, Glasgow, Oxford, Plymouth, Preston

2015-11-19

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 September 2026. https://priyalifescience.com/clinical-trials-uk/city/preston

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →